Atherosclerosis and Lipoproteins |
From the Institute of Biochemistry (H.K., M.A., C.G.), Humboldt University Medical School Charité, Berlin and Institute for Vascular Medicine (A.H.), Friedrich-Schiller-University of Jena, Germany.
Correspondence to Dr Hartmut Kuhn, Institute of Biochemistry, University Clinics Charité, Humboldt University, Monbijoustr. 2, 10117 Berlin, F.R. Germany. E-mail hartmut.kuehn{at}charite.de
Objectives The mouse strain CON6, which was generated by breeding athero-resistant CAST mice into an athero-susceptible B6 background, exhibits almost complete resistance to atherosclerosis. An athero-resistance gene cluster has been localized at the central region of chromosome 6, and among the candidate genes of this locus, the 5-lipoxygenase has attracted particular attention because of its involvement in the biosynthesis of proinflammatory leukotrienes. Comparison of 5-lipoxygenase genomic sequences of B6 and CON6 mice indicated 2 conserved amino acid exchanges in the CON6 animals, but the functional impact of these mutations has not been defined.
Methods and Results We analyzed the functionality of these amino acid exchanges relative to essential catalytic properties (specific activity, substrate affinity, and reaction specificity) and found that these mutations confer an impaired lipoxygenase and leukotriene A4-synthase activity when introduced into the human enzyme. In contrast, substrate affinity, enantiomer selectivity, and positional specificity remained unchanged.
Conclusions These data are consistent with the possibility that naturally occurring conservative mutations in the coding region of the murine 5-lipoxygenase gene can significantly affect enzyme activity and that this loss of function may be involved in CAST/CON6 athero-resistance.
Key Words: eicosanoids leukotrienes inflammation mutation atherogenesis
This article has been cited by other articles:
![]() |
M. Mehrabian Response to Arachidonate 5-Lipoxygenase Variants in Atherosclerosis, Obesity, and Bone Traits Circ. Res., May 12, 2006; 98(9): e68 - e68. [Full Text] [PDF] |
||||
![]() |
M. A. Lyons Arachidonate 5-Lipoxygenase Variants in Atherosclerosis, Obesity, and Bone Traits Circ. Res., April 28, 2006; 98(8): e66 - e66. [Full Text] [PDF] |
||||
![]() |
J. A. Leopold and J. Loscalzo Oxidative Enzymopathies and Vascular Disease Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1332 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Allayee, A. Ghazalpour, and A. J. Lusis Using Mice to Dissect Genetic Factors in Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1501 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lotzer, R. Spanbroek, M. Hildner, A. Urbach, R. Heller, E. Bretschneider, H. Galczenski, J. F. Evans, and A. J.R. Habenicht Differential Leukotriene Receptor Expression and Calcium Responses in Endothelial Cells and Macrophages Indicate 5-Lipoxygenase-Dependent Circuits of Inflammation and Atherogenesis Arterioscler Thromb Vasc Biol, August 1, 2003; 23(8): e32 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Radmark 5-Lipoxygenase-Derived Leukotrienes: Mediators Also of Atherosclerotic Inflammation Arterioscler Thromb Vasc Biol, June 1, 2003; 23(7): 1140 - 1142. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |